This document details the agreement between the Department of Health and the Association of the British Pharmaceutical Industry (ABPI) on the outline terms of the 2014 PPRS.
The new scheme will provide assurance on almost all of the branded medicines bill for the NHS. The bill will stay flat over the next two years and will grow slowly after that. The industry will make payments to the Department of Health if NHS spending on branded medicines exceeds the allowed growth rate.
The PPRS is a voluntary agreement to control the prices of branded drugs sold to the NHS. It is negotiated between the Department of Health, acting on behalf of the UK government and Northern Ireland, and the branded pharmaceutical industry, represented by the ABPI.
The full 2014 PPRS will be published later this year.